Manufacturer copay assistance · Evkeeza (J1305) · Regeneron
$45/dose · Maximum benefit Up to $25,000 per calendar year · Covers Evkeeza drug cost and infusion administration — does not cover office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Yes — myRARE Co-pay Assistance from Regeneron. Patient pays $45 per treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $45 per treatment Maximum benefit: Up to $25,000 per calendar year. Covers Evkeeza drug cost and infusion administration — does not cover office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.